You are here

Article info

Article menu
XML
Neurogastroenterology
Original article
Randomised controlled trial of mesalazine in IBS

Authors

  1. Correspondence to Dr Giovanni Barbara, Department of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital—Building # 5, Via Massarenti, Bologna 9-I-40138, Italy; giovanni.barbara{at}unibo.it
View Full Text

Citation

Barbara G, Cremon C, Annese V, et al
Randomised controlled trial of mesalazine in IBS
Gut 2016;65:82-90.

Publication history

  • Received August 2, 2014
  • Revised November 18, 2014
  • Accepted November 20, 2014
  • First published December 22, 2014.
Online issue publication 
April 18, 2016

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/